Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice?

Gianluigi Reda, MD, Ramona Cassin, Veronica Mattiello, Tatiana Tonella, Diana Giannarelli, PhD, Bruno Fattizzo, MD, Francesco Onida, MD, Ferdinando Maria Massari, Agostino Cortelezzi, Prof

Blood (2017) 130 (Supplement 1): 1747.

https://doi.org/10.1182/blood.V130.Suppl_1.1747.1747

Published: 2017

Journal Articles

Cardiac Complications in Thrombotic Thrombocytopenic Purpura: Data from Nationwide Inpatient Sample

Ranjan Pathak, MD, Madan Raj Aryal, MD, Smith Giri, MD, Paras Karmacharya, MD, Anthony A Donato, MDMHPE

Blood (2014) 124 (21): 2793.

https://doi.org/10.1182/blood.V124.21.2793.2793

Published: 2014

Journal Articles

Chronic Graft Versus Host Disease (GVHD) Does Not Impact Cardiovascular Risk Factors in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation (SCT) up to the Second Decade Post-Transplant,

Priyanka A Pophali, MD, Kamna Chawla, MD, MS, Eleftheria K. Koklanaris, BSN, Avan Antia, Simar Chawla, Sawa Ito, MD, Jeffrey K. Klotz, MD, Robert Q. Le, MD, PhD, A. John Barrett, MD, FRCP, Minoo Battiwalla, MD, MS

Blood (2011) 118 (21): 4099.

https://doi.org/10.1182/blood.V118.21.4099.4099

Published: 2011

Journal Articles

Preliminary Results From a Phase III Trial of Imatinib Versus Imatinib in Combination with Cytarabine in Patients with First Chronic Phase Myeloid Leukemia

Noortje Thielen, Bronno van der Holt, Jan J Cornelissen, MD PhD, Rianne Ammerlaan, Pieter Sonneveld, MD, PhD, Marie José Kersten, J.H. Frederik Falkenburg, Harm Sinnige, Martin Schipperus, Anton Schattenberg, Marinus van Marwijk Kooy, Willem Smit, Gregor Verhoef, Isabel Chu, Peter Valk, Jeroen JWM Janssen, MD PhD, Gert Ossenkoppele, MD, PhD

Blood (2011) 118 (21): 2758.

https://doi.org/10.1182/blood.V118.21.2758.2758

Published: 2011

Journal Articles

Corrected QT Interval Is Related to Markers of Hemolysis and Tricuspid Regurgitant Jet Velocity in a Young Cohort with Sickle Cell Disease.

Robert I. Liem, MD, Luciana T. Young, MD, Alexis A. Thompson, MD, MPH

Blood (2007) 110 (11): 2258.

https://doi.org/10.1182/blood.V110.11.2258.2258

Published: 2007

NARROW

Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice?

Cardiac Complications in Thrombotic Thrombocytopenic Purpura: Data from Nationwide Inpatient Sample

Chronic Graft Versus Host Disease (GVHD) Does Not Impact Cardiovascular Risk Factors in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation (SCT) up to the Second Decade Post-Transplant,

Preliminary Results From a Phase III Trial of Imatinib Versus Imatinib in Combination with Cytarabine in Patients with First Chronic Phase Myeloid Leukemia

Corrected QT Interval Is Related to Markers of Hemolysis and Tricuspid Regurgitant Jet Velocity in a Young Cohort with Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice?

Cardiac Complications in Thrombotic Thrombocytopenic Purpura: Data from Nationwide Inpatient Sample

Chronic Graft Versus Host Disease (GVHD) Does Not Impact Cardiovascular Risk Factors in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation (SCT) up to the Second Decade Post-Transplant,

Preliminary Results From a Phase III Trial of Imatinib Versus Imatinib in Combination with Cytarabine in Patients with First Chronic Phase Myeloid Leukemia

Corrected QT Interval Is Related to Markers of Hemolysis and Tricuspid Regurgitant Jet Velocity in a Young Cohort with Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only